Elham Mahmoudi Maymand
Overview
Explore the profile of Elham Mahmoudi Maymand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maghsoodi N, Zareinejad M, Ghaderi A, Mahmoudi Maymand E, Irajie C, Ramezani A
Cytokine
. 2024 Dec;
185:156822.
PMID: 39631260
Background: To overcome the limitations of IL-15 and to improve the efficacy of IL-15 in immunotherapy, several strategies have been introduced. Objective: The objective of this study was to generate...
2.
Ahmadi N, Zareinejad M, Ameri M, Mahmoudi Maymand E, Nooreddin Faraji S, Ghaderi A, et al.
Cytokine
. 2024 Feb;
176:156505.
PMID: 38301357
Background: There are a number of distinct challenges and complexities associated with administering IL-15 for cancer immunotherapy that must be taken into consideration. Objective: The purpose of this study was...
3.
Maghsoodi N, Zareinejad M, Golestan A, Mahmoudi Maymand E, Ramezani A
Cell Immunol
. 2023 Nov;
393-394:104787.
PMID: 37976975
The administration of blinatumomab was accompanied by several adverse effects, including activation of regulatory T-cells and cytokine storm. The objective of this study was to produce and evaluate a novel...
4.
Ramezani A, Zareinejad M, Mahmoudi Maymand E, Kaviani E, Ghaderi A
Growth Factors
. 2023 Jun;
41(3):140-151.
PMID: 37377438
This project aimed to produce a biosimilar version of aflibercept (AFL) and evaluate the effect of the co-treatment of AFL with other vascular endothelial growth factor (VEGF) blocker drugs. For...
5.
Mazloomrezaei M, Hosseini M, Ahmadi N, Mahmoudi Maymand E, Eftekhar E, Asgari A, et al.
Iran J Immunol
. 2022 Dec;
19(4):436-445.
PMID: 36585885
Background: It is advantageous to develop an effective purification procedure to produce recombinant protein drugs (rPDs) without any tags. To remove N- or C-terminus tags from the rPDs, several cleavage...
6.
Kaviani E, Hosseini A, Mahmoudi Maymand E, Ramzi M, Ghaderi A, Ramezani A
PLoS One
. 2022 Dec;
17(12):e0275777.
PMID: 36480493
Tumor infiltrating lymphocytes (TILs) usually become exhausted and dysfunctional owing to chronic contact with tumor cells and overexpression of multiple inhibitor receptors. Activation of TILs by targeting the inhibitory and...
7.
Toghraie F, Yazdanpanah-Samani M, Mahmoudi Maymand E, Hosseini A, Asgari A, Ramezani A, et al.
Iran J Allergy Asthma Immunol
. 2019 Sep;
18(4):419-426.
PMID: 31522450
Granulocyte colony-stimulating factor (G-CSF) is the major regulator of hemopoiesis and granulopoiesis. However, overexpression of G-CSF has been implicated in several important processes in tumor biology such as tumor growth,...
8.
Yousefinejad F, Jowkar F, Barani S, Jamali E, Mahmoudi E, Ramezani A, et al.
Iran Biomed J
. 2019 May;
23(5):330-7.
PMID: 31103021
Background: The innate immune system against malignancies is mainly orchestrated by natural killer cells, which carry out killing mechanisms by using their receptors, such as killer immunoglobulin-like receptors (KIRs). This...
9.
Arshi A, Sharifi F, Khorramian Ghahfarokhi M, Faghih Z, Doosti A, Ostovari S, et al.
Mol Ther Nucleic Acids
. 2018 Aug;
12:751-757.
PMID: 30126830
Breast cancer, as the most common cancer in women worldwide, represents about 30% of all cancers affecting women. Long non-coding RNAs (lncRNAs) have been implicated in the regulation of several...
10.
Toghraie F, Sharifzadeh S, Ramezani A, Mahmoudi Maymand E, Yazdanpanah-Samani M, Ghaderi A
Rep Biochem Mol Biol
. 2017 Nov;
6(1):66-73.
PMID: 29090231
Background: The critical role of interleukin-7 (IL-7) in homeostatic proliferation and T cell survival has made it a promising cytokine for the treatment of various clinical conditions, especially those associated...